Attached files
| file | filename |
|---|---|
| 10-K - CAPRICOR THERAPEUTICS, INC. | v214527_10k.htm |
| EX-31.1 - CAPRICOR THERAPEUTICS, INC. | v214527_ex31-1.htm |
| EX-32.2 - CAPRICOR THERAPEUTICS, INC. | v214527_ex32-2.htm |
| EX-31.2 - CAPRICOR THERAPEUTICS, INC. | v214527_ex31-2.htm |
| EX-32.1 - CAPRICOR THERAPEUTICS, INC. | v214527_ex32-1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements of Nile Therapeutics, Inc. on Form S-8 (File No. 333-152283) and Form S-3 (File No. 333-165167) of our report dated March 14, 2011, relating to the financial statements, appearing in this Annual Report on Form 10-K of Nile Therapeutics, Inc. for the year ended December 31, 2010, and to the reference to us under the heading “Experts” in the prospectus.
/s/ Crowe Horwath LLP
New York, New York
March 14, 2011